Akanda (NASDAQ: AKAN) reported Q2 2023 earnings per share (EPS) of N/A, up N/A year over year. Total Akanda earnings for the quarter were N/A. In the same quarter last year, Akanda's earnings per share (EPS) was N/A.
As of Q1 2024, Akanda's earnings has grown year over year. Akanda's earnings in the past year totalled -$14.94 million.
What was AKAN's revenue last quarter?
Akanda (NASDAQ: AKAN) reported Q2 2023 revenue of N/A up N/A year over year. In the same quarter last year, Akanda's revenue was N/A.
What was AKAN's revenue growth in the past year?
As of Q1 2024, Akanda's revenue has grown 3,466.29% year over year. This is 3,456.57 percentage points higher than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 9.72%. Akanda's revenue in the past year totalled $3.94 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.